Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
Background: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis. Methods: In this analytical study with longitudinal follow up...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-03-01
|
Series: | Artery Research |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125924994/view |
_version_ | 1818038100067090432 |
---|---|
author | Venkatesh Arumugam Abhijeet Saha Manpreet Kaur Kanika Kapoor Nimisha Arora Trayambak Basak Shantanu Sengupta Ajay Bhatt Nitin Bharadwaj Vineeta V. Batra Ashish Datt Upadhyay |
author_facet | Venkatesh Arumugam Abhijeet Saha Manpreet Kaur Kanika Kapoor Nimisha Arora Trayambak Basak Shantanu Sengupta Ajay Bhatt Nitin Bharadwaj Vineeta V. Batra Ashish Datt Upadhyay |
author_sort | Venkatesh Arumugam |
collection | DOAJ |
description | Background: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis.
Methods: In this analytical study with longitudinal follow up 25 children with first episode of nephrotic syndrome (FENS) aged 1–16 years along with 25 age and gender matched healthy controls were enrolled. Endothelin 1 (ET 1) levels were measured by ELISA (Cloud Clone Corp. and assembled by USCN Inc, U.S.A). Other variables were measured using standard biochemical methods. Primary outcome measure was plasma ET 1 level in children with FENS and in controls. Secondary outcome measure was to observe the levels of ET 1 in children with FENS at 12 weeks in remission.
Results: The level of ET 1 was significantly higher (p < 0.001) in children with FENS as compared to controls. The level of ET 1 was significantly higher (p = 0.006) in SSNS at the onset of nephrotic syndrome and was significantly lower (p = 0.04) after 12 weeks of drug induced remission as compared to controls. SRNS children had higher levels of ET 1 than the steroid sensitive patients at onset but in was not statistically significant (p = 0.062). ET 1 showed significant positive correlation with total cholesterol (r = 0.462; p = 0.001) and negative correlation with serum albumin (r = −0.565; p = 0.001).
Conclusion: Plasma ET 1 levels are raised in children with FENS posing a risk of endothelial dysfunction, which persists at least in short term. Long term effects of raised plasma ET 1 needs to be studied. |
first_indexed | 2024-12-10T07:37:22Z |
format | Article |
id | doaj.art-519bd151d73d4619b5163910a265bed8 |
institution | Directory Open Access Journal |
issn | 1876-4401 |
language | English |
last_indexed | 2024-12-10T07:37:22Z |
publishDate | 2017-03-01 |
publisher | BMC |
record_format | Article |
series | Artery Research |
spelling | doaj.art-519bd151d73d4619b5163910a265bed82022-12-22T01:57:24ZengBMCArtery Research1876-44012017-03-011810.1016/j.artres.2017.02.006Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndromeVenkatesh ArumugamAbhijeet SahaManpreet KaurKanika KapoorNimisha AroraTrayambak BasakShantanu SenguptaAjay BhattNitin BharadwajVineeta V. BatraAshish Datt UpadhyayBackground: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis. Methods: In this analytical study with longitudinal follow up 25 children with first episode of nephrotic syndrome (FENS) aged 1–16 years along with 25 age and gender matched healthy controls were enrolled. Endothelin 1 (ET 1) levels were measured by ELISA (Cloud Clone Corp. and assembled by USCN Inc, U.S.A). Other variables were measured using standard biochemical methods. Primary outcome measure was plasma ET 1 level in children with FENS and in controls. Secondary outcome measure was to observe the levels of ET 1 in children with FENS at 12 weeks in remission. Results: The level of ET 1 was significantly higher (p < 0.001) in children with FENS as compared to controls. The level of ET 1 was significantly higher (p = 0.006) in SSNS at the onset of nephrotic syndrome and was significantly lower (p = 0.04) after 12 weeks of drug induced remission as compared to controls. SRNS children had higher levels of ET 1 than the steroid sensitive patients at onset but in was not statistically significant (p = 0.062). ET 1 showed significant positive correlation with total cholesterol (r = 0.462; p = 0.001) and negative correlation with serum albumin (r = −0.565; p = 0.001). Conclusion: Plasma ET 1 levels are raised in children with FENS posing a risk of endothelial dysfunction, which persists at least in short term. Long term effects of raised plasma ET 1 needs to be studied.https://www.atlantis-press.com/article/125924994/viewEndothelin 1Nephrotic syndromeEndothelial dysfunctionChildren |
spellingShingle | Venkatesh Arumugam Abhijeet Saha Manpreet Kaur Kanika Kapoor Nimisha Arora Trayambak Basak Shantanu Sengupta Ajay Bhatt Nitin Bharadwaj Vineeta V. Batra Ashish Datt Upadhyay Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome Artery Research Endothelin 1 Nephrotic syndrome Endothelial dysfunction Children |
title | Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
title_full | Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
title_fullStr | Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
title_full_unstemmed | Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
title_short | Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
title_sort | endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome |
topic | Endothelin 1 Nephrotic syndrome Endothelial dysfunction Children |
url | https://www.atlantis-press.com/article/125924994/view |
work_keys_str_mv | AT venkatesharumugam endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT abhijeetsaha endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT manpreetkaur endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT kanikakapoor endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT nimishaarora endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT trayambakbasak endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT shantanusengupta endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT ajaybhatt endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT nitinbharadwaj endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT vineetavbatra endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome AT ashishdattupadhyay endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome |